Literature DB >> 8930693

Plastic responses of neonatal 5-hydroxytryptamine1B receptors to 5,7-dihydroxytryptamine lesions mapped by quantitative autoradiography.

M R Pranzatelli1, M M Durkin, M Farmer.   

Abstract

We previously found different effects on behavior, serotonin (5-HT) concentrations, 5-HT uptake sites, and 5-HT1A binding sites of neonatal 5,7-dihydroxytryptamine (5,7-DHT) lesions depending on the route of 5,7-DHT injection. To study the impact of early lesions on 5-HT1B sites as putative 5-HT terminal autoreceptors, we labelled them autoradiographically with [3H]5-HT 4 months after intraperitoneal (i.p.) or intracisternal (i.c.) 5,7-DHT injection during the first postnatal week and quantitated specific binding in 22 brain regions. Changes were confined to the subiculum and substantia nigra, regions with the most 5-HT1B-specific binding and projection areas of structures with high mRNA expression. Both routes of 5,7-DHT injection were associated with increases in specific binding in subiculum (24% for i.p. and 47% for i.c. route). In contrast, there was a 32% increase in specific binding in the substantia nigra in rats with lesions made i.c. but not i.p. No significant differences were found in nucleus accumbens, caudate-putamen or other brain areas. In saturation homogenate binding studies of 5-HT1B sites using [125I]iodocyanopindolol 1 month after i.p. injections, neonatal 5,7-DHT lesions did not significantly alter Bmax or Kd in the neocortex, striatum, diencephalon or brainstem. These data indicate the differential effects of the route of neonatal 5,7-DHT injections on plasticity of 5-HT1B receptor recognition sites and suggest the presence of a subpopulation of post-synaptically located 5-HT1B sites which increases in response to denervation. The data also suggest that sprouting of 5-HT neurons after neonatal 5,7-DHT lesions does not involve 5-HT1B sites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930693

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  4 in total

1.  A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors.

Authors:  Katherine M Nautiyal; Laurent Tritschler; Susanne E Ahmari; Denis J David; Alain M Gardier; René Hen
Journal:  Neuropsychopharmacology       Date:  2016-06-29       Impact factor: 7.853

Review 2.  Regulation of dorsal raphe nucleus function by serotonin autoreceptors: a behavioral perspective.

Authors:  Ross A McDevitt; John F Neumaier
Journal:  J Chem Neuroanat       Date:  2011-05-08       Impact factor: 3.052

3.  The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding.

Authors:  James W Murrough; Christoph Czermak; Shannan Henry; Nabeel Nabulsi; Jean-Dominique Gallezot; Ralitza Gueorguieva; Beata Planeta-Wilson; John H Krystal; John F Neumaier; Yiyun Huang; Yu-Shin Ding; Richard E Carson; Alexander Neumeister
Journal:  Arch Gen Psychiatry       Date:  2011-09

4.  In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study.

Authors:  Jonas E Svensson; Mikael Tiger; Pontus Plavén-Sigray; Christer Halldin; Martin Schain; Johan Lundberg
Journal:  Neuropsychopharmacology       Date:  2022-07-11       Impact factor: 8.294

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.